Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN||042A21A / UNK||- / -|
Administered by: Other Purchased by: ??
Symptoms: Nasopharyngitis, Productive cough, Injection site swelling
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': USJNJFOC20210708303
Write-up: COUGHING UP PHLEGM; GENERAL COLD-LIKE SYMPTOMS; SWELLING AT INJECTION SITE; This spontaneous report received from a patient concerned a male of unspecified age. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 22-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On JUN-2021, the subject experienced swelling at injection site. On 02-JUL-2021, the subject experienced coughing up phlegm. On 02-JUL-2021, the subject experienced general cold-like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling at injection site, and had not recovered from coughing up phlegm, and general cold-like symptoms. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166